The global Dry Eye Syndrome Treatment Market was valued at USD 6.7 billion in 2025 and is projected to grow from USD 7.1 billion in 2026 to USD 11.1 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. North America dominated the market with the largest revenue share of 40.3% in 2025, driven by a high prevalence of dry eye disease, strong healthcare infrastructure, growing...

North America remains a key regional market for vitrectomy devices due to the growing burden of retinal diseases, rising healthcare expenditure, and increasing adoption of minimally invasive ophthalmic procedures. The presence of advanced medical facilities, favorable reimbursement frameworks, and ongoing technological advancements in vitreoretinal surgery are contributing to sustained market...